Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
autoSTEM-OA and alloSTEM-OA in Knee Osteoarthritis
NCT05789719Phase 1Unknown
- Sponsor
- StemMedical
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of STEM-OA in osteoarthritis (OA) (6 arms), sponsored by StemMedical. Primary endpoint: STEM-OA safety at 13 weeks. Status: unknown.
02
Drugs
STEM-OA
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05789719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05789719.